Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Link between interleukin-10 level and outcome after ischemic stroke.

Chang LT, Yuen CM, Liou CW, Lu CH, Chang WN, Youssef AA, Yip HK.

Neuroimmunomodulation. 2010;17(4):223-8. doi: 10.1159/000290038. Epub 2010 Mar 5.

PMID:
20203528
2.

IL-6: an early marker for outcome in acute ischemic stroke.

Waje-Andreassen U, Kråkenes J, Ulvestad E, Thomassen L, Myhr KM, Aarseth J, Vedeler CA.

Acta Neurol Scand. 2005 Jun;111(6):360-5.

PMID:
15876336
3.

Level and value of interleukin-18 after acute ischemic stroke.

Yuen CM, Chiu CA, Chang LT, Liou CW, Lu CH, Youssef AA, Yip HK.

Circ J. 2007 Nov;71(11):1691-6.

4.
5.

The value of leukocyte adhesion molecules in patients after ischemic stroke.

Tsai NW, Chang WN, Shaw CF, Jan CR, Huang CR, Chen SD, Chuang YC, Lee LH, Lu CH.

J Neurol. 2009 Aug;256(8):1296-302. doi: 10.1007/s00415-009-5117-3. Epub 2009 Apr 8.

PMID:
19353220
6.

Evaluation of the inflammatory response in sera from acute ischemic stroke patients by measurement of IL-2 and IL-10.

Nayak AR, Kashyap RS, Purohit HJ, Kabra D, Taori GM, Daginawala HF.

Inflamm Res. 2009 Oct;58(10):687-91. doi: 10.1007/s00011-009-0036-4. Epub 2009 Apr 2.

PMID:
19340396
7.

Serum level and prognostic value of neopterin in patients after ischemic stroke.

Lin HS, Tsai TH, Liu CF, Lu CH, Chang WN, Chen SF, Huang CW, Huang CR, Tsai NW, Huang CC, Liou CW, Lin TK, Lan MY, Yip HK.

Clin Biochem. 2012 Dec;45(18):1596-601. doi: 10.1016/j.clinbiochem.2012.07.113. Epub 2012 Aug 8.

PMID:
22892193
8.

Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke.

Katan M, Fluri F, Schuetz P, Morgenthaler NG, Zweifel C, Bingisser R, Kappos L, Steck A, Engelter ST, Müller B, Christ-Crain M.

J Am Coll Cardiol. 2010 Sep 21;56(13):1045-53. doi: 10.1016/j.jacc.2010.02.071.

9.

Plasma proinflammatory and anti-inflammatory cytokine and catecholamine concentrations as predictors of neurological outcome in acute stroke patients.

Oto J, Suzue A, Inui D, Fukuta Y, Hosotsubo K, Torii M, Nagahiro S, Nishimura M.

J Anesth. 2008;22(3):207-12. doi: 10.1007/s00540-008-0639-x. Epub 2008 Aug 7.

PMID:
18685925
10.

Elevated pro-inflammatory CD4+CD28- lymphocytes and stroke recurrence and death.

Nadareishvili ZG, Li H, Wright V, Maric D, Warach S, Hallenbeck JM, Dambrosia J, Barker JL, Baird AE.

Neurology. 2004 Oct 26;63(8):1446-51.

PMID:
15505163
11.

The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome.

Worthmann H, Tryc AB, Goldbecker A, Ma YT, Tountopoulou A, Hahn A, Dengler R, Lichtinghagen R, Weissenborn K.

Cerebrovasc Dis. 2010;30(1):85-92. doi: 10.1159/000314624. Epub 2010 May 19.

PMID:
20484906
12.

Inflammation markers and prediction of post-stroke vascular disease recurrence: the MITICO study.

Castillo J, Alvarez-Sabín J, Martínez-Vila E, Montaner J, Sobrino T, Vivancos J; MITICO Study Investigators..

J Neurol. 2009 Feb;256(2):217-24. doi: 10.1007/s00415-009-0058-4. Epub 2009 Feb 27.

PMID:
19252763
13.

Stroke scale score and early prediction of outcome after stroke.

Ahmed R, Zuberi BF, Afsar S.

J Coll Physicians Surg Pak. 2004 May;14(5):267-9.

PMID:
15225452
14.

Probable role of immunological tolerance to ischemia injury in brain.

Beridze M, Shakarishvili R, Gogokhia N.

Georgian Med News. 2008 Oct;(163):30-5.

PMID:
18997250
15.

Prognostic value of neuron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficit.

Singh HV, Pandey A, Shrivastava AK, Raizada A, Singh SK, Singh N.

Clin Chim Acta. 2013 Apr 18;419:136-8. doi: 10.1016/j.cca.2013.02.014. Epub 2013 Feb 21.

PMID:
23438682
16.

Elevated serum urate concentration independently predicts poor outcome following stroke in patients with diabetes.

Newman EJ, Rahman FS, Lees KR, Weir CJ, Walters MR.

Diabetes Metab Res Rev. 2006 Jan-Feb;22(1):79-82.

PMID:
16088970
17.

Osteopontin predicts long-term functional outcome among ischemic stroke patients.

Mendioroz M, Fernández-Cadenas I, Rosell A, Delgado P, Domingues-Montanari S, Ribó M, Penalba A, Quintana M, Alvarez-Sabín J, Montaner J.

J Neurol. 2011 Mar;258(3):486-93. doi: 10.1007/s00415-010-5785-z. Epub 2010 Oct 22.

PMID:
20967551
18.

Serum albumin in ischemic stroke patients: the higher the better. The Bergen Stroke Study.

Idicula TT, Waje-Andreassen U, Brogger J, Naess H, Thomassen L.

Cerebrovasc Dis. 2009;28(1):13-7. doi: 10.1159/000215938. Epub 2009 May 6.

PMID:
19420917
19.

Recovery after ischemic stroke: criteria for good outcome by level of disability at day 7.

Hallevi H, Albright KC, Martin-Schild SB, Barreto AD, Morales MM, Bornstein N, Ifejika NL, Shuaib A, Grotta JC, Savitz SI; VISTA investigators..

Cerebrovasc Dis. 2009;28(4):341-8. doi: 10.1159/000229552. Epub 2009 Jul 24.

PMID:
19628935
20.

The decrease in procarboxypeptidase U (TAFI) concentration in acute ischemic stroke correlates with stroke severity, evolution and outcome.

Brouns R, Heylen E, Willemse JL, Sheorajpanday R, De Surgeloose D, Verkerk R, De Deyn PP, Hendriks DF.

J Thromb Haemost. 2010 Jan;8(1):75-80. doi: 10.1111/j.1538-7836.2009.03663.x. Epub 2009 Oct 23.

Supplemental Content

Support Center